Nexentis Technologies Inc.
NXTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001789192
No open-market purchases or sales by Nexentis Technologies Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $272.3K in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Nexentis Technologies Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 9 | 13 | +4 |
| Shares | 122.1K | 280.6K | +158.5K (+129.8%) |
| Value | $72.9K | $142.7K | +$69.8K (+95.7%) |
New holders (6)
Institutions that held Nexentis Technologies Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Group Inc | 76,844 | $39.3K | 0.00% |
| Geode Capital Management, LLC | 32,366 | $16.6K | 0.00% |
| Renaissance Technologies LLC | 26,308 | $13.0K | 0.00% |
| UBS Group AG | 17,702 | $9.05K | 0.00% |
| HRT Financial LP | 14,755 | $7.00K | 0.00% |
| Meridian Wealth Management, LLC | 10,000 | $5.11K | 0.00% |
Sold out (2)
Institutions that held Nexentis Technologies Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Ameritas Advisory Services, LLC | 15,000 | $8.78K |
| Bank Julius Baer & Co. Ltd, Zurich | 4,906 | $3.00K |